Related Experiment Video
Updated: Aug 20, 2026

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
Published on: August 28, 2013
Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor
Pier Paolo Sainaghi1, Luigi Castello, Luca Bergamasco
1Department of Medical Sciences, Università del Piemonte Orientale "A. Avogadro," Novara, Italy.
Abstract:
Axl is a tyrosine kinase receptor and although it is expressed in malignancy such as leukemia, colon cancer, melanoma, endometrial, prostate and thyroid cancers, its role has not been completely elucidated yet and appears to be complex. The ligand of Axl, Gas6, is a 75 KDa multimodular protein with an N-terminal gamma-carboxy-glutamic acid that is essential for binding. Gas6 has a mitogenic effect on several normal cell lines. The receptor Axl is expressed in primary prostate carcinoma and in prostate cancer cell lines as such as PC-3 and DU 145. We demonstrated a mitogenic activity determined by Gas6/Axl interaction in these undifferentiated metastatic human prostatic cancer cell lines. This effect is proportional to Axl expression, not due to inhibition of apoptosis, and induces AKT and MAPK phosphorylation. However, only MEK phosphorylation seems to be essential for growth signaling. Our results suggest that Axl overexpression and activation by Gas6 could be involved in progression of prostate neoplastic disease.
Insights
Gas6 protein activates the Axl receptor tyrosine kinase, promoting mitogenic effects in prostate cancer cells. This Gas6/Axl interaction, particularly MEK phosphorylation, may drive prostate cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Axl receptor tyrosine kinase is implicated in various malignancies, but its precise role remains complex and not fully understood.
- Gas6, the ligand for Axl, is a protein known to exert mitogenic effects on normal cell lines.
- Axl expression is detected in primary prostate carcinoma and associated cell lines like PC-3 and DU 145.
Purpose of the Study:
- To investigate the role of Gas6/Axl interaction in driving mitogenic activity in undifferentiated, metastatic human prostate cancer cell lines.
- To elucidate the downstream signaling pathways affected by Gas6/Axl activation in prostate cancer.
Main Methods:
- Utilized prostate cancer cell lines (PC-3, DU 145) expressing Axl receptor.
- Assessed the mitogenic effects of Gas6 stimulation.
- Analyzed downstream signaling by measuring phosphorylation of AKT and MAPK pathways, specifically focusing on MEK.
Main Results:
- Demonstrated a Gas6-dependent mitogenic effect in Axl-expressing prostate cancer cells.
- Observed that the mitogenic effect correlated with Axl expression levels.
- Identified AKT and MAPK phosphorylation, with MEK phosphorylation being crucial for the growth signaling.
Conclusions:
- Axl receptor tyrosine kinase and its ligand Gas6 play a significant role in promoting prostate cancer cell proliferation.
- Gas6/Axl signaling, through MEK phosphorylation, appears to be a key driver of prostate cancer progression.
- Targeting the Gas6/Axl pathway could represent a potential therapeutic strategy for prostate cancer.
More Related Videos
Related Concept Videos
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
Mitogens and the Cell Cycle
TGF - β Signaling Pathway

